Make prevention a priority by vaccinating against meningococcal disease
Prevalence of Meningococcal Disease by Serogroup in the US2,*
N=563
*In patients aged <1 to ≥65 years, from 2009-2018.
†Includes W and serogroups unable to be identified.
Help protect appropriate patients with meningitis vaccines
Are you up-to-date on the CDC MenB vaccination recommendation?
Trademarks are owned by or licensed to the GSK group of companies.
This website is funded and developed by GSK.
This site is intended for US healthcare professionals only.
The GSK Response Center is available to answer your questions at 1-888-593-5977, Monday-Friday, 8:30 am - 5:30 pm ET.
During the hours the GSK Response Center is not available, please feel free to Contact GSK.